Company intelligence / Profile preview

RSSL

Reading, England, UKrssl.com ↗

Ownership: Private
Employees: ~300
Development stage: Other

Overview

RSSL provides contract research and analytical services to the life sciences sector. It does not run clinical trials or develop its own drugs but supports pharmaceutical and biotech companies from early R&D through commercial release with GMP-compliant testing, regulatory consultancy, stability studies, training, and innovation support. Its new Innovation Hub offers tailored support to early-stage biotechs developing cell/gene therapies, vaccines, medical devices and more.

Modalities: Small moleculeBiologicMonoclonal antibodyCell therapyGene therapyVaccine
Industry: Drug Discovery Services

Partnerships

Supports all top global pharma companies as clients; no specific partnerships disclosed

Beyond the preview

Go deeper on RSSL.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RSSL.

Explore the full profile